AXGN - CIK 0000805928
The table below shows Axogen, Inc.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | $812.00K | $4.54M | -$5.72M | -$16.07M | -$13.40M | -$9.63M |
| Capital expenditure | $3.75M | $3.10M | $13.87M | $20.08M | $27.81M | $21.91M |
| Investing cash flow | -$5.32M | -$10.30M | $19.25M | -$3.20M | -$23.65M | -$16.96M |
| Dividends paid | - | - | - | - | - |
Axogen, Inc. reported operating cash flow of $812.00K for fiscal year 2025. That is down 82.1% from $4.54M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from -$11.24M (FY 2016) to $812.00K. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | $10.50M | $2.29M | $1.95M | $1.79M | $20.45M | $40.47M |